BioAtla's market cap is currently $26.03M. The company's EPS TTM is $-1.699; its P/E ratio is ―; BioAtla is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 250.00K	$ 429.00K	$ 5.20M
Gross Profit	$ -103.73M	$ -1.20M	$ -1.08M	$ 409.07K	$ 5.17M
Operating Income	$ -129.69M	$ -108.14M	$ -96.44M	$ -30.10M	$ -28.27M
EBITDA	$ -122.24M	$ -106.48M	$ -94.07M	$ -33.46M	$ -27.36M
Net Income	$ -123.46M	$ -105.28M	$ -95.41M	$ -37.24M	$ -31.40M
Balance Sheet
Cash & Short-Term Investments	$ 111.47M	$ 215.51M	$ 244.98M	$ 238.60M	$ 3.70M
Total Assets	$ 119.66M	$ 225.74M	$ 254.42M	$ 244.94M	$ 9.34M
Total Debt	$ 2.46M	$ 3.98M	$ 5.37M	$ 682.00K	$ 18.12M
Net Debt	$ -109.01M	$ -211.53M	$ -239.61M	$ -237.92M	$ 14.42M
Total Liabilities	$ 48.99M	$ 45.40M	$ 43.60M	$ 34.96M	$ 65.35M
Stockholders' Equity	$ 70.67M	$ 180.34M	$ 210.82M	$ 209.97M	$ -55.96M
Cash Flow
Free Cash Flow	$ -104.11M	$ -90.69M	$ -63.14M	$ -36.92M	$ -11.15M
Operating Cash Flow	$ -104.02M	$ -90.42M	$ -62.21M	$ -36.33M	$ -9.64M
Investing Cash Flow	$ -98.00K	$ -265.00K	$ -924.00K	$ -590.00K	$ -1.51M
Financing Cash Flow	$ 77.00K	$ 61.21K	$ 69.51M	$ 271.82M	$ 4.00M

Currency in USD

BioAtla Earnings and Revenue History

Income Statement >

BioAtla Debt to Assets

Balance Sheet >

BioAtla Cash Flow

Cash Flow >

BioAtla Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing